Cryptosporidiosis among Hemodialysis Patients in Jordan: First Preliminary Screening Surveillance

Molecular, Microscopic, and Immunochromatographic Detection of Enteroparasitic Infections in Hemodialysis Patients and Related Risk Factors

Intestinal parasitic infection (IPI) is one of the important causes of morbidity and mortality in patients with chronic renal failure (CRF). Patients with CRF are more prone to infections due to acquired immunodeficiency caused by uremia. This study aims at determining the prevalence of parasitic intestinal infections in hemodialysis (HD) patients in Makkah, Saudi Arabia, and at comparing the techniques used for the detection of intestinal parasites. One hundred stool samples were collected from Saudi HD patients from two dialysis centers of two hospitals in Makkah City, and 50 samples were collected randomly from healthy individuals that served as control. The laboratory tests were carried out at King Fahd Medical Research Center, King Abdulaziz University, Jeddah. One stool sample was collected from each participant and examined with different techniques. The diagnosis was carried out using the direct wet smear with normal saline and native-Lugol's, Ritchie technique, rapid diagnostic test (ImmunoCard STAT! CGE), and molecular techniques (real-time polymerase chain reaction). The relation between age, gender, weight, and height to calculate body mass index, level of education, time of the HD, lifestyle, residence status, several gastrointestinal symptoms, blood pressure, diabetes, irritable bowel disease, and other factors was studied. Intestinal parasites were found in 38% of the HD patients and 36% of the control group. The most encountered intestinal parasites in the HD patients and control group were Blastocystis hominis (31%) and (34%), Entamoeba histolytica (3%) and (2%) respectively, Endolimax nana (4%) in the HD group, Giardia lamblia (4%) in the control group, and no positive results for Cryptosporidium or helminths in both groups. The IPIs should be suspected in all cases of immunodeficient patients, and stool samples should be ordered as routine with other tests in interval times and examined using special techniques. The physicians should be aware of the similarity between HD and intestinal parasitosis symptoms to perform diagnostic tests and determine the suitable treatment.

Cryptosporidium and colorectal cancer: a review of epidemiology and possible association

Cryptosporidiosis is an important protozoan disease with serious public health implications. The contribution of Cryptosporidium to colorectal cancer is still vaguely studied, but little evidence from experimental and epidemiological studies has suggested a possible association. This review discusses the epidemiology of cryptosporidiosis and colorectal cancer and attempts to unravel the possible link between the two diseases using epidemiological, pathological, molecular, and immunological evidence. The review stressed the need to undertake more studies in this relatively neglected field.

Molecular characterization of Entamoeba, Blastocystis and Cryptosporidium species in stool samples collected from Jordanian patients suffering from gastroenteritis

Little is known about the prevalence of intestinal protozoa in patients suffering from diarrhea in Jordan. The present study aimed to detect and speciate Entamoeba, Blastocystis, and Cryptosporidium species in a total of 159 human patients with diarrhea from November 2014 to October 2016. The overall prevalence for the three parasites was 19.5% (31/159). Entamoeba spp. (Entamoeba. dispar and/or Entamoeba histolytica), Blastocystis hominis, and Cryptosporidium parvum subtype IIaA15G2R1 were detected in 12.6%, 6%, and 0.6 of samples, respectively. This is the first molecular study in Jordan to confirm the diagnosis of Entamoeba species and to discriminate between E. histolytica and E. dispar.

Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries

Cryptosporidiosis is one of the most important causes of moderate to severe diarrhea and diarrhea-related mortality in children under 2 years of age in low- and middle-income countries. In recent decades, genotyping and subtyping tools have been used in epidemiological studies of human cryptosporidiosis. Results of these studies suggest that higher genetic diversity of Cryptosporidium spp. is present in humans in these countries at both species and subtype levels and that anthroponotic transmission plays a major role in human cryptosporidiosis. Cryptosporidium hominis is the most common Cryptosporidium species in humans in almost all the low- and middle-income countries examined, with five subtype families (namely, Ia, Ib, Id, Ie, and If) being commonly found in most regions. In addition, most Cryptosporidium parvum infections in these areas are caused by the anthroponotic IIc subtype family rather than the zoonotic IIa subtype family. There is geographic segregation in Cryptosporidium hominis subtypes, as revealed by multilocus subtyping. Concurrent and sequential infections with different Cryptosporidium species and subtypes are common, as immunity against reinfection and cross protection against different Cryptosporidium species are partial. Differences in clinical presentations have been observed among Cryptosporidium species and C. hominis subtypes. These observations suggest that WASH (water, sanitation, and hygiene)-based interventions should be implemented to prevent and control human cryptosporidiosis in low- and middle-income countries.